Anzeige
Mehr »
Donnerstag, 26.06.2025 - Börsentäglich über 12.000 News
TAO +1.800?%, SBAR +85?%, CYK +280?% - jetzt startet KORA auf Unternehmensebene durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40PMQ | ISIN: CA58471K2020 | Ticker-Symbol: N460
Frankfurt
25.06.25 | 15:29
2,060 Euro
+1,98 % +0,040
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDICUS PHARMA LTD Chart 1 Jahr
5-Tage-Chart
MEDICUS PHARMA LTD 5-Tage-Chart

Aktuelle News zur MEDICUS PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoMedicus Pharma appoints Andrew Smith as chief operating officer2
MoMedicus Pharma ernennt Andrew Smith zum Chief Operating Officer 2
MoMedicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer184Philadelphia, Pennsylvania--(Newsfile Corp. - June 23, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the appointment of Andrew Smith as Chief Operating...
► Artikel lesen
FrMedicus Pharma Ltd. - 8-K, Current Report1
12.06.Medicus Pharma Ltd. to Present at 2025 Bio International Convention203Philadelphia, Pennsylvania--(Newsfile Corp. - June 12, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the schedule of the presentation of Dr. Raza Bokhari...
► Artikel lesen
MEDICUS PHARMA Aktie jetzt für 0€ handeln
09.06.Medicus Pharma advances cancer patch for horses2
09.06.Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses193Philadelphia, Pennsylvania--(Newsfile Corp. - June 9, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce submission of a comprehensive product development...
► Artikel lesen
02.06.Medicus Pharma Ltd. - 8-K, Current Report-
02.06.Medicus Pharma schließt öffentliches Angebot über 7 Millionen US-Dollar ab1
02.06.Medicus Pharma completes $7 million public offering1
02.06.Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering271Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000...
► Artikel lesen
30.05.Pre-market Movers: Bolt Projects, Basel Medical Group, Red Robin Gourmet Burgers, LZ Technology, Medicus Pharma746OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 06.55 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 114%...
► Artikel lesen
30.05.Medicus Pharma prices $7 million share offering1
30.05.Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering314Philadelphia, Pennsylvania--(Newsfile Corp. - May 29, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of its public offering of 2,260,000 units, on a "best-efforts"...
► Artikel lesen
27.05.Medicus Pharma Ltd. - S-1, General form for registration of securities1
22.05.Medicus Pharma Ltd.: Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)353Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has received study may proceed approval...
► Artikel lesen
12.05.Medicus Pharma Ltd. - 10-Q, Quarterly Report2
12.05.Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio3
12.05.Medicus Pharma stock target lifted to $27 on Antev acquisition2
05.05.Medicus Pharma Ltd. - 8-K, Current Report-
Weiter >>
67 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1